anzchog2023-logo-website-md

ASM History

2022 Annual Scientific Meeting

Nurses Workshop

The pre-ASM nursing workshop is included with the Full ASM Delegate registration type. Space for this workshop is limited and you will need to indicate during the registration process if you would like to attend.

Venue: Hyde Park Room, Sheraton Grand Hyde Park, Sydney

0900-1700

ANZCHOG Nurses Pre Conference Workshop Program

Chair: Chrissy Hanmore

0900-0905
Welcome & housekeeping
0905-0950

The importance of self-care and the impact of the pandemic

Dr Justin Baker

St Jude Children’s Research Hospital

0950-1035
Hiding in plain sight. Nursing’s superpower

Prof Mei Krishnasamy
Peter MacCallum Cancer Centre
1035-1055
Morning tea
1055-1120

Genomics and targeted therapy in childhood cancer

Dr Loretta Lau
Kids Cancer Centre SCH

1120-1145
Haemophilia overview and what’s the treatment plan for 2022

Grainne Dunne
Sydney Children’s Hospital
1145-1210
Fertility and emerging therapies

Tejnei Vaishnav
Royal Hospital for Women, NSW
1210-1230
The role and value of the research nurse

A/Prof Natalie Bradford
Queensland University of Technology
1230-1300
Lunch
1300-1430
What’s on your eLearning wishlist? eviQ Education showcase and workshop
1430-1450

The Druggle, Improving Paediatric Oncology Drug Knowledge in Real Time

Ms Genevieve Daly
Kids Cancer Centre, Sydney Children's Hospital

1450-1505
Afternoon tea
1505-1535
Navigating end-of-life conversations with adolescents and young adults using the Australian Voicing My Choices tool: best practice & case examples

Dr Ursula Samson-Daly, Cath O’Dwyer & Fiona Maguire

Sydney Children’s Hospital
1535-1605
Children and Adolescents with Cancer: Neuropsychological effects, education needs and interventions
Dr Soheil Afshar
Sydney Children’s Hospital

1605-1635

Health and wellbeing after cancer: a multidisciplinary program for long-term survivors of childhood malignancies

Dr Christina Signorelli, Karen Johnston & Rachael Bell

Sydney Children’s Hospital
 
Presented by Dr Jordana McLoone & Rachael Bell
1635-1700

ANZCHOG Nurses Update, Evaluations and Close

Brought to you by

Parent Program

You will have the option to register your attendance to the Parent Program during the registration process for the ASM.

If you would like to attend the virtual Parent Program only please proceed via the standard registration portal and use registration code*: PAR22 when prompted in order to bypass the ASM registration.

*Please note, by using this code, you will not be registered to attend the ASM or any of the social functions.

Example

0930-1510
AEST
Parent Program
Chair: Donna Drew
0930-0935
Welcome and house keeping for virtual attendees
0935-0955
Keeping up with school during and after childhood cancer

Joanna Fardell

0955-1015

Managing social challenges during and after childhood cancer

Clarissa Schilstra
1015-1030
Questions
1030-1045
Morning tea
1045-1115

When your child has cancer, goals of care, hope and compassion

Justin Baker

1115-1145
Minimising the psychological impact of cancer treatment on children and adolescents

Liane Willis
1145-1215
Questions
1215-1300
Lunch
 
1240-1300: Lunch session: "Would a national voice from parents lead to improved cancer support for families?" AND "What steps could be taken to build that voice?"
 
A discussion led by Tim Rogers from Redkite
Chair: Joanna Fardell
1300-1320
Staying fit and active during and after cancer

Lauren Ha
1320-1340
Managing the needs of siblings who have a brother or sister with cancer

Brittany McGill
1350-1400
Afternoon tea
1400-1420
When and how do I talk to my child about their cancer experience : side effects, experience, fertility

Tali Foreman
1420-1440
Survivor’s Story: Clarissa will share her story about her cancer diagnosis, relapse, survivorship, academic achievements and being a mum

Clarissa
1500-1510
Summary of the day & close

The Parent Day program is scheduled in AEST.

Brought to you by

0900-0915
Opening ceremony
0915-1015
Plenary 1
Location: Grand Ballroom
Chair: Dr Richard Mitchell


Improving patient outcomes through integrated paediatric palliative care

Dr Justin Baker

St Jude Children’s Research Hospital


The ASM would like to acknowledge The Kids' Cancer Project for the support of Dr Justin Baker's attendance as an invited speaker.

1015-1045
Morning tea - Trade display and poster viewing
1045-1130
Plenary 2
Location: Grand Ballroom

Chair: Dr Richard Mitchell

Old drugs and new: Still so much to learn about haemostasis in children
Prof Paul Monagle
Kids Cancer Centre, Sydney Children's Hospital/University of Melbourne

1130-1215
Plenary 3
Location: Grand Ballroom
Chair: Dr Richard Mitchell


Fertility preservation in young people: The new standard of care
Dr Yasmin Jayasinghe
Royal Children’s Hospital Melbourne
1215-1315
Lunch - Trade display and poster viewing
1245-1315
Partner lunch symposium 1
Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT
Location: Hyde Park Room

Prof Selim Corbacioglu
Children's Hospital Regensburg Germany

Brought to you by

1315-1445
Concurrent 1: Non malignant haematology
Concurrent 2: Translational Medicine
Concurrent 3: Patient experience
Location: Ballroom 1
Location: Ballroom 2
Location: Hyde Park Room
Chair: Prof Paul Monagle


Current management of sickle cell disease

Dr Anthea Greenway

Royal Children's Hospital Melbourne


Iron deficiency anaemia

Prof Sant-Rayn Parischa


Walter and Eliza Hall Institute of Medical Research


Transfusion medicine

Dr Gemma Crighton

Royal Children's Hospital Melbourne
Chair: Dr Noemi Fuentes Bolanos

Computational Biology in Oncology Drug Discovery
A/Prof Antoine de Weck
Children's Cancer Institute

A Comprehensive Patient-Derived Xenograft Model Platform to Support
Translational Neuroblastoma Research
Dr Jamie Fletcher
Children's Cancer Institute

A novel paediatric oncology mouse clinic
Ms Zahra Abbas
Telethon Kids Institute

Targeting the Anti-apoptotic Protein BCL2 With Venetoclax Combination Treatment in High-risk Neuroblastoma
Ms Madeleine Wheatley
Children's Cancer Institute

Exploiting Arginine Addiction to Treat High-Risk Neuroblastoma
Dr Kimberley Hanssen
Children's Cancer Institute
Chair: Donna Drew


Hoping against hope - Supporting hope in advancing illness

Dr Justin Baker

St Jude Children's Hospital Memphis


The ASM would like to acknowledge The Kids' Cancer Project for the support of Dr Justin Baker's attendance as an invited speaker.






ASSET: Collecting patient toxicity data and quality of life data together, where to next?

Dr Joanna Fardell

Kids Cancer Centre, Sydney Children's Hospital


Do long term survivors adhere to recommendations provided by MDT review?

Dr Jordana McLoone

Kids Cancer Centre, Sydney Children's Hospital


Developing a model of care for AYA patients with culturally diverse backgrounds

Dr Azhani Amiruddin

Crown Princess Mary Cancer Centre
1445-1515
Afternoon tea - Trade display and poster viewing
1515-1700
Concurrent 4: Non malignant haematology
Concurrent 5: Solid tumours
Concurrent 6: Patient experience
Location: Ballroom 1
Location: Ballroom 2
Location: Hyde Park Room

Chair: Prof Paul Monagle

Novel treatments of ITP
Dr Sally Campbell
Royal Brisbane & Women's Hospital

Current care in haemophilia
Janine Furmedge
Royal Children's Hospital Melbourne

National guidelines for ITP
Dr Tina Carter & Dr Vanessa Verissimo
Perth Children's Hospital 

Chair: Dr Felicity Wright

Current therapies in neuroblastoma
Dr Toby Trahair
Kids Cancer Centre, Sydney Children's Hospital

Recruitment principles and strategies for supportive care research in paediatric oncology
A/ Prof Natalie Bradford
Queensland University of Technology

The outcome of paediatric extracranial malignant germ cell tumours: ten years experience of a single institution in Southern Vietnam
Dr T. T. An Dao
University of Medicine and Pharmacy At Ho Chi Minh City

The NCI/COG Molecular Characterisation Project and Zero2 - an update
Prof Nick Gottardo
Perth Children's Hospital
A/Prof Vanessa Tyrrell
Children's Cancer Institute

Chair: Chrissy Hanmore

Health workers' understanding of and barriers to palliative care services for Aboriginal children with cancer
Dr Sophie Jessop
Kids Cancer Centre SCH

“Torn in Two” Experiences of mothers who are pregnant when their child is diagnosed with cancer
Ms Jenny Davies
Curtin University

Identifying education and employment outcomes and support needs in Adolescents and Young Adults diagnosed with cancer
Dr Jennifer Cohen
Canteen, Australia

Fathers’ Experiences of Childhood Cancer
Ms Jenny Davies
Curtin University

Home-Based Hydration for Chemotherapy – Its Clinical Impact and the Experience of Paediatric Oncology Patients and Their Families
Mrs Jennifer Arguelles
Paediatric Integrated Cancer Service

The management of pain for children hospitalised during Haematopoietic Stem Cell Transplantation
Dr Karin Plummer
Griffith University

1700-1900
Welcome reception
0730-0830
Partner breakfast 1
CAR-T for ALL IN 2022
Partner breakfast 2
Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology
Location: Ballroom 1
Location: Hyde Park Room

SeongLin Khaw
Royal Children’s Hospital, Melbourne

Brought to you by

Chair: Professor Nick Gottardo
Perth Children’s Hospital

Dr Brendan McMullan
Sydney Children’s Hospital

Dr Daniel Yeoh
Perth Children’s Hospital

Brought to you by

0900-1000
Plenary 4
Location: Grand Ballroom

Chair: Prof Claire Wakefield

You should ask that: The different faces of life after treatment

Dr Robert Battisti
Children's Hospital Westmead

1000-1030
Morning tea - Trade display and poster viewing
1030-1130

ANZCHOG 2022 Best abstracts

Location: Grand Ballroom
Chair: Dr Richard Mitchell

Molecular monitoring of ctDNA in neuroblastoma patients for response monitoring and relapse prediction
Dr Vinod Vijay Subhash
Children's Cancer Institute

Cardio-oncology guidelines for paediatric oncology patients: A Delphi consensus approach to inform risk stratification, surveillance and management during active cancer therapy.
Mr Ben Felmingham
Murdoch Children's Research Institute

Generation and Multi-Dimensional Profiling of a Childhood Cancer Cell Line Atlas Defines New Therapeutic Opportunities
Dr Paul Daniel
Hudson Institute Of Medical Research

1130-1200

ANZCHOG foundations lecture

Location: Grand Ballroom

Chair: Prof Les White

A history of paediatric stem cell transplantation in Australia

Prof Marcus Vowels

1200-1300
Lunch - Trade display and poster viewing
1225-1255
Partner lunch symposium 2
Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer
Location: Hyde Park Room

Professor David Ziegler
Kids Cancer Centre

MD Theodore W. Laetsch
Children’s Hospital of Philadelphia/University of Pennsylvania

Brought to you by

1300-1430
Concurrent 7: Neuro-oncology
Concurrent 8: Precision medicine
Concurrent 9: Global oncology in Oceania: A joint SIOP-ANZCHOG symposium across disciplines
Location: Ballroom 2
Location: Ballroom 1
Location: Hyde Park Room

Chair: Dr Neevika Manoharan

Holistic care for paediatric brain tumours: 2022 and beyond
A/Prof Jordan Hansford
Women's and Children's Hospital Adelaide

The ASM would like to acknowledge the Robert Connor Dawes Foundation for the support of A/Prof Jordan Hansford's attendance as an invited speaker.

Epigenetic regulation of innate signaling in brain tumours: Implications for novel therapeutic approaches.
Dr David M. Ashley
Duke University

Preliminary Analysis of the Pharmaco-phospho-proteo-genomic Landscape of Paediatric High-grade Gliomas
Mr Izac Findlay
University Of Newcastle

Determining the Clinical Utility of the Immune Modulating Antibody Anti-CD47 in a Preclinical Model of Medulloblastoma.
Dr Meegan Howlett
Telethon Kids Institute

The development of ACT001 as a novel combination therapeutic for diffuse intrinsic pontine gliomas
Dr Dannielle Upton
Children's Cancer Institute

Chair: Dr Karen McCleary

Precision Medicine 101
Dr Loretta Lau
Kids Cancer Centre SCH

High-Throughput Drug Testing on Patient-Derived Models Identifies Novel Rational Treatment Options for Paediatric Cancer Patients
Dr Emmy Dolman
Children's Cancer Institute

Precision medicine is changing the roles of healthcare professionals, scientists, and research staff: Learnings from a childhood cancer precision medicine trial.
Ms Rebecca Daly
UNSW

Chairs: Professor Claire Wakefield & Dr Michael Sullivan

Improving child cancer care in Oceania, working with the World Health Organisation, and welcome remarks from global leaders
Professor Claire Wakefield
Continental President of SIOP Oceania

Working together to support regional development of child cancer care: The ARIA Global Guideline Collaboration
Professor Michael Sullivan (Chair SIOP Global Health)

Supporting nursing education in Oceania: What’s going on in our neighbourhood?
Ms Jayne Harrison

A showcase of child cancer care strengths and challenges in our region, featuring clinicians from Papua New Guinea, Fiji, New Caledonia, Tonga and Timor Leste
Dr Gwenda Anga, Papua New Guinea; Dr Miri Thaggard, Fiji; Dr Gregory Harvet, New Caledonia; Dr Meleane Toafa, Tonga, Dr Milena Santos, Timor Leste

Discussion and Q&A

1430-1500
Afternoon tea - Trade display and poster viewing
1500-1630
Concurrent 10: Neuro-oncology
Concurrent 11: Leukaemia/Cellular Therapy
Concurrent 12: ANZCHOG Trial & Research updates
Location: Ballroom 2
Location: Ballroom 1
Location: Hyde Park Room
Chair: Prof Richard Cohn

Long-term control and safety of larotrectinib in a cohort of adult and paediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumours
A/ Prof Jordan Hansford
Women's and Children's Hospital Adelaide

Australasian Methylation Array Profiling – an Update on the AIM BRAIN PROject
Dr Christine White
Victorian Clinical Genetics Services

Characteristics of Children with Brain Cancer: A 10-Year Retrospective Cohort
A/ Prof Natalie Bradford
Queensland University of Technology

Preclinical optimisation of the PI3K/AKT/mTOR inhibitor paxalisib for the treatment of diffuse intrinsic pontine glioma
Dr Ryan Duchatel
University Of Newcastle

Chair: Dr Adam Nelson

CAR-T cells for B-ALL: Real world data and beyond
MD Theodore W. Laetsch

Children’s Hospital of Philadelphia/University of Pennsylvania

Cooperative deletions of key lymphoid transcription factors strongly associated with recurrent genomic lesions in B-cell acute lymphoblastic leukaemia
Ms Jacqueline Rehn
South Australian Health and Medical Research Institute

Vincristine-Induced Peripheral Neuropathy: Assessing Preventable Strategies in Paediatric Acute Lymphoblastic Leukemia.
Dr Benjamin Schreiber
Children's Cancer Institute

Reinventing The Wheel - Changing High Dose Methotrexate Habits
Dr Phoebe Power
Sydney Children's Hospital

Chimeric Antigen Receptor (CAR) T cell Therapy: Updated Outcomes at a Single Centre
Dr Seong Lin Khaw
Royal Children's Hospital Melbourne

Chair: Dr Maria Kirby

1500-1515: Registries, biobanking and supportive care research

1515-1545: Leukaemia/lymphoma and solid tumours clinical trials

1545-1625: CNS clinical trials and ZERO2 initiatives

1625-1630: Trial governance updates

1630-1700
Meet the experts 1
Clinical use of asparaginase

Meet the expert 2
Dinutuximab beta as immunotherapy in high-risk neuroblastoma

Location: Ballroom 1
Location: Ballroom 2

Dr Siobhan Cross
Canterbury District Health Board

Jessica Nicholson
Children's Health Queensland

Brought to you by

Dr Martin Campbell
Royal Children’s Hospital Melbourne

Dr Aleksandra Wieczorek
University Children’s Hospital, Krakow

Brought to you by

1900-2300
Gala dinner
The Eveleigh, Bay 3, 2 Locomotive St, Eveleigh NSW 2015
0900-1100
Panel discussion
Location: Grand Ballroom
Moderator: Annabel Crabb

ABC journalist


Ava’s Journey – Decision making in the age of early phase trials


Panelists:

Prof David Ziegler, Kids Cancer Centre, Sydney Children's Hospital;

Dr Justin Baker, St. Jude Children’s Research Hospital;

Prof Mary Chiarella, University of Sydney;

Ben Charlton

Maryanne Larkin
1100-1130
Morning tea - Trade display and poster viewing
1130-1230
Plenary 5
Location: Grand Ballroom
Chair: Dr Richard Mitchell


Communication as a Cornerstone of Care: What We Say and How We Say It Matters


Dr Justin Baker

St Jude Children's Hospital Memphis


The ASM would like to acknowledge The Kids' Cancer Project for the support of Dr Justin Baker's attendance as an invited speaker.


1230-1300
Closing ceremony
Location: Grand Ballroom
Chair: Dr Richard Mitchell



Best abstract awards


Thanks for attending ASM 2022


Join us for ASM 2023
Day 1 - Thursday 28 July
1245 - 1315
Partner Lunch Symposium
Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT
Prof Selim Corbacioglu
Children's Hospital Regensburg Germany


Brought to you by


Day 2 - Friday 29 July
0730 - 0830
Partner breakfast 1
CAR-T for ALL IN 2022
Partner breakfast 2

Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology

SeongLin Khaw
Royal Children’s Hospital, Melbourne

Brought to you by

Chair: Professor Nick Gottardo
Perth Children’s Hospital

Dr Brendan McMullan
Sydney Children’s Hospital

Dr Daniel Yeoh
Perth Children’s Hospital

Brought to you by

1225 - 1255
Partner Lunch Symposium 2
Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer

Professor David Ziegler
Kids Cancer Centre

MD Theodore W. Laetsch
Children’s Hospital of Philadelphia/University of Pennsylvania

Brought to you by

1630 - 1700
Meet the experts 1
Clinical use of asparaginase
Meet the experts 2
Dinutuximab beta as immunotherapy in high-risk neuroblastoma

Dr Siobhan Cross
Canterbury District Health Board

Jessica Nicholson
Children's Health Queensland

Brought to you by

Dr Martin Campbell
Royal Children’s Hospital Melbourne

Dr Aleksandra Wieczorek
University Children’s Hospital, Krakow

Brought to you by

Day 2 - Friday 29 July
0730 - 0830

Brought to you by

Professor Nick Gottardo
Perth Children’s Hospital, Australia

Dr Brendan McMullan
Sydney Children’s Hospital, Australia

Dr Daniel Yeoh
Perth Children’s Hospital, Australia

Brought to you by

1230 - 1300
Partner Lunch Symposium 2
Efficacy and safety of larotrectinib in pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer
Professor David Ziegler
Kids Cancer Centre

MD Theodore W. Laetsch
Children’s Hospital of Philadelphia/University of Pennsylvania

Brought to you by


1630 - 1700
Meet the experts 1
Clinical use of asparaginase
Meet the experts 2
Dinutuximab beta as immunotherapy in high-risk neuroblastoma

Dr Siobhan Cross
Canterbury District Health Board

Jessica Nicholson
Children's Health Queensland

Brought to you by

Dr Martin Campbell
Royal Children’s Hospital Melbourne

Dr Aleksandra Wieczorek
University Children’s Hospital, Krakow

Brought to you by

Other Invited Speakers

Dr Tina Carter

Perth Children’s Hospital

Janine Furmedge

Royal Children’s Hospital Melbourne

Dr Anthea Greenway

Royal Children’s Hospital Melbourne

Dr Jordana McLoone

Kids Cancer Centre, Sydney Children’s Hospital

Prof Sant-Rayn Parischa

Walter and Eliza Hall Institute of Medical Research

Join the ASM mailing list

Stay informed about the latest updates. This can include speakers, abstract submission information, program updates, and other important updates. 

* indicates required

Website update

Abstracts now open

View Abstract guidelines and make a submission via the Abstract page

Important dates

  • Submissions open: Now
  • Submissions close: May 2023
  • Notifications of successful abstracts: June 2023

17 February, 2023